AzTrials
AzTrials

Diabetes Mellitus Type 2NCT07783451

Effectiveness of Combining Patient Follow-Up With an Educational Intervention on Self-Management Skills of Type 2 Diabetes Mellitus Patients: A Controlled Intervention Study in Primary Care

A study testing A structured shared follow-up plan combined with patient education in people with Diabetes Mellitus Type 2, run by Aysenur Aktemur at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this clinical study is to evaluate whether patient education provided in conjunction with a structured, shared follow-up plan in primary care strengthens the self-management skills of patients with Type 2 Diabetes (T2DM). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Diabetes Mellitus Type 2
What is being tested?
A structured shared follow-up plan combined with patient education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
84 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 May 2021to 30 Jan 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Must have a documented clinical diagnosis of Type 2 Diabetes Mellitus (T2DM).
  • Must be literate (able to read and write).
  • Must be able to monitor/measure blood glucose at home.

Who cannot join

  • Inability to complete/apply the health literacy scale independently.
  • Currently receiving specialized diabetes care or treatment from a tertiary/specialized diabetes center.
  • Hospitalization due to diabetes-related complications during the course of the study.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Marmara University Pendik Training and Research Hospital Tuzla Primary Health Center

    Istanbul, 34953

Other trials in Turkey (Türkiye)

About this study

Official title: The Impact of a Collaborative Follow-up Plan Developed Through Patient-Physician Cooperation in Primary Care on Self-Management of Type 2 Diabetes Mellitus Patients: A Non-Randomized Controlled Study.

The purpose of this clinical study is to evaluate whether patient education provided in conjunction with a structured, shared follow-up plan in primary care strengthens the self-management skills of patients with Type 2 Diabetes (T2DM). The study also aims to determine whether the effect of this intervention is associated with patients' baseline levels of health literacy.

The key questions this study aims to address are as follows:

Read more
  1. Do the structured follow-up model and educational intervention improve diabetes self-management skills (healthy lifestyle behaviors, blood glucose management, and use of health services) among patients with T2DM?
  2. Can this improvement in diabetes self-management skills occur regardless of patients' baseline levels of health literacy? To measure the effectiveness of structured follow-up in improving diabetes self-management, researchers will compare the intervention group-which receives in-person sessions supported by visual aids-with the control group, which is followed up via standard phone calls.

Participants will go through the following processes in the study:

Participants in the Intervention Group:

For three months, they will attend monthly in-person (or video-based, upon request) follow-up sessions with their family physicians. The first session lasts approximately 45 minutes, the second 20 minutes, and the third 15 minutes.

Together with their doctors, they will complete a "Diabetes (DM) ID Card" and receive education on diabetes care and monitoring for complications.

At home, they will monitor their own blood sugar levels, perform foot checks, and record this data in the "DM Diary" developed by the researchers.

At the clinic, they will undergo screenings for complications such as neuropathy, including foot examinations and the monofilament test, performed by their family physicians.

They will review changes in diet and physical activity with their physicians. At the start of the study and at the end of the third month, they will complete self-management and health literacy assessment scales.

Participants in the Control Group:

For three months, they will receive monthly phone calls from their family physicians lasting approximately 10 minutes, which will include general information about diabetes and reminders about complication screenings (eye, foot, and kidney examinations).

Participants will complete the diabetes self-management assessment scale at the start of the study and again at the end of the third month.

Read the detailed description

For use in the clinicaltrials.gov registration of this clinical trial, a comprehensive "Detailed Description" text-which does not contradict the "Brief Summary" section or repeat the information contained therein and which includes the technical and scientific background-has been prepared below:

  1. Scientific Rationale and Background The prevalence of diabetes is rapidly increasing worldwide; according to data from the International Diabetes Atlas 2025, an estimated 588.7 million people aged 20-79 have diabetes, and this number is expected to reach 822.5 million by 2050. The TURDEP-2 study conducted across Turkey also revealed a similar upward trend, showing that the prevalence of diabetes rose from 7.2% to 13.7% over a 12-year period (1998-2010). The long-term microvascular and macrovascular complications of diabetes constitute a significant disease burden; for example, diabetic nephropathy-the most common cause of end-stage renal disease in developed countries-develops in 20-40% of people with Type 2 Diabetes (T2DM) and increases the risk of cardiovascular mortality. Additionally, diabetic neuropathy-characterized by symmetrical loss of sensation-and peripheral vascular disease are the primary causes of foot ulcers and form the basis of diabetic foot cases, leading to approximately 12,000 amputations annually across Turkey. Primary care providers are responsible for regularly monitoring patients with diabetes, recommending screenings for complications, and educating patients on how to protect themselves from these complications. However, effective control of the disease requires patients to take responsibility for managing their own condition (self-management). Individuals with low health literacy (HL) have a higher risk of developing diabetes complications (particularly neurovascular complications and retinopathy), and these patients are less likely to have sufficient knowledge about diabetes care and self-care activities. According to data from the Turkey Health Literacy Survey, 24.5% of the population has inadequate health literacy, while 40.1% has problematic health literacy. Although there are many educational programs in the literature aimed at supporting diabetes self-management, the majority of these studies have been conducted in secondary or tertiary care facilities or specialized diabetes centers; however, access to such multidisciplinary expert teams is quite limited in communities with scarce resources. Therefore, there is a need for structured intervention models that can be implemented at the primary care level, aim to improve self-management skills even among patients with low health literacy, and are based on physician-patient collaboration.
  2. Study Design and Sample Size This study was designed as a pre-test/post-test comparative, non-randomized controlled clinical trial. The study was conducted at three different primary care centers in Istanbul. Instead of randomization, center-based grouping was chosen; patients registered at ASM-A formed the intervention group (IG), while those registered at ASM-B and ASM-C formed the control group (CG). This design was chosen to prevent patients at the same center from interacting with one another and sharing information (the contamination effect). The study's sample size was calculated using the Clinical Sample Size Calculator (ClinCalc) program, targeting a minimum increase of 8 points in self-management scale scores in the intervention group following the intervention, at a 95% confidence level and 80% power. Accordingly, with a 1:1 ratio, at least 40 participants were planned for each group, and the study was completed with a total of 84 patients.
  3. Theoretical Framework of the Intervention (Theoretical Framework of the Intervention) In educating patients with low health literacy, evidence-based strategies such as using simple language, focusing on direct actions, limiting the number of messages, taking cultural differences into account, supporting instructions with visual aids, and continuously monitoring the patient's level of understanding (teach-back method) have been adopted. Developed in line with these principles, the "Diabetes (DM) ID Card" and "DM Diary" have been visually enriched and prepared in extremely simple language to enable patients to manage their own self-care without being overwhelmed by complex medical information. Instead of conducting a traditional, one-way educational session, an interactive follow-up model was implemented in which the physician and patient engage in a two-way dialogue, and the patient actively shares their habits and the challenges they face. During this process, patients received in-person training from their physicians on how to perform daily blood glucose monitoring and self-examinations of their feet.
  4. Data Collection Tools and Scales (Measurement Instruments) Data from participants were collected using the following valid and reliable instruments administered by family physicians at the initial visit and at the end of the third month: Sociodemographic Questionnaire: A form prepared by the researchers that asks patients about their age, gender, education, income level, smoking and alcohol habits, and comorbidities. Hacettepe University Adult Health Literacy Scale Short Form (HU-SOÖ): A 24-item measure with two dimensions-Health Literacy and Self-Efficacy-and a Cronbach's alpha value of 0.84. The scale does not have a specific cut-off point; higher scores indicate a higher level of health literacy. Type 2 Diabetes Self-Management Scale (DÖYÖ): A 19-item scale using a 5-point Likert scale with a Cronbach's alpha value of 0.86. The scale consists of three subscales: "Healthy Lifestyle Behaviors," "Blood Sugar Management," and "Use of Health Services."
  5. Statistical Analysis Plan All data obtained in this study were analyzed using IBM SPSS version 23.0. Categorical variables were described using frequencies and percentages; the distribution of continuous variables was assessed using the Kolmogorov-Smirnov test and by examining kurtosis and skewness values. The chi-square and McNemar tests were used for categorical comparisons between groups. In the analysis of continuous variables, the paired t-test and independent samples t-test were used for data showing a normal distribution; for data not normally distributed, the Wilcoxon signed-rank test was preferred. Correlations between variables were calculated using Pearson or Spearman tests. An intent-to-treat (ITT) analysis was applied to control for the effect of patients who were lost to follow-up on the analysis. In this context, the post-test scores of 5 patients from each group who were unable to attend follow-up visits for various reasons (unreachability or death) were included in the analysis without assuming any change (while retaining their baseline scores).
  6. Ethical Approval and Permissions (Ethical Approvals) The ethical compliance of the study was approved by the Marmara University Faculty of Medicine Clinical Research Ethics Committee on May 7, 2021 (Protocol Code: 09.2021.601). Additionally, an official research permit (No. 2021/44) was obtained from the Istanbul Provincial Health Directorate on October 11, 2021.
Being tested
A structured shared follow-up plan combined with patient education
Keywords
Self-Management, Patient-Empowerment, Primary Care
Medical subject headings
Diabetes Mellitus, Type 2, Patient Participation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • A structured shared follow-up plan combined with patient educationBehavioural

    This intervention consists of a structured, patient-centered diabetes self-management program integrated into routine primary care, specifically designed to address low health literacy. Delivered face-to-face (or via video call) by family physicians over three monthly sessions of decreasing duration (approximately 45, 20, and 15 minutes, respectively). It utilizes low-literacy communication strategies, including plain language, action-focused messaging, visual aids, and the 'teach-back' method to confirm and reinforce understanding.

Study groups in NCT07783451
Study groupRoleWhat they receive
Intervention GroupExperimentalNot described
Receives: Behavioral: A structured shared follow-up plan combined with patient education
Control GroupNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Type 2 Diabetes Self-Management Scale (DSMS) Total Score

    The DSMS is a validated 19-item scale designed to assess diabetes self-management skills in patients with type 2 diabetes. It uses a 5-point Likert-type scoring system. The total score ranges from 19 to 95, with higher scores indicating a higher level of diabetes self-management skills. This outcome measure evaluates the change in total self-management skills from baseline to the end of the 3-month follow-up period.

    Measured: Baseline and 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Aug 2026
  2. Study start1 May 2021
  3. Primary completion30 Jan 2022
  4. Study completion30 Jan 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Patients who were registered to Intervention Group were interviewed face-to-face or by video call once a month by the family physician (FP) according to the participant's request. A shared follow-up plan was created. For this purpose, a DM identity card was given to the patients and filled out together with the patient. Patients were also asked to complete a Blood Glucose Measurement and Foot Check Diary and were instructed on how to complete it. In Control Group FP informed the patients in the CG about basic DM care by phone calls once a month lasting 10 minutes
Masking
None (open label)
Enrolment
84 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07783451
Sponsor's protocol ID
09.2021.601
Status last verified
Aug 2026
First submitted
20 Aug 2026
Last updated
27 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing A structured shared follow-up plan combined with patient education in people with Diabetes Mellitus Type 2, run by Aysenur Aktemur at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Type 2 Diabetes Self-Management Scale (DSMS) Total Score (time frame: Baseline and 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in